Valero Energy Corporation (VLO) Q4 2025 Earnings Call Transcript — Neutral

VLO   Seeking Alpha — January 29, 2026

Valero Energy Corporation (VLO) Q4 2025 Earnings Call Transcript

image for news Valero Energy Corporation (VLO) Q4 2025 Earnings Call Transcript

CSW Industrials, Inc. (CSW) Q3 2026 Earnings Call Transcript — Neutral

CSW   Seeking Alpha — January 29, 2026

CSW Industrials, Inc. (CSW) Q3 2026 Earnings Call Transcript

image for news CSW Industrials, Inc. (CSW) Q3 2026 Earnings Call Transcript

Liberty Energy Inc. (LBRT) Q4 2025 Earnings Call Transcript — Neutral

LBRT   Seeking Alpha — January 29, 2026

Liberty Energy Inc. (LBRT) Q4 2025 Earnings Call Transcript

image for news Liberty Energy Inc. (LBRT) Q4 2025 Earnings Call Transcript

Public Storage's Slow Phase Is A Long-Term Opportunity — Positive

PSA   Seeking Alpha — January 29, 2026

Public Storage is rated a Buy, with current valuations near decade lows despite strong margins and a robust balance sheet. PSA's growth is driven by capital deployment and acquisitions, with gradual earnings impact due to initially lower margins in new properties. Same-store NOI margins remain high at 78.5%, but organic growth is muted and occupancy is drifting slightly lower.

image for news Public Storage's Slow Phase Is A Long-Term Opportunity

VRNS Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing a notice to investors in Varonis Systems, Inc. (NASDAQ: VRNS) regarding the approaching March 9, 2026, lead plaintiff deadline in a pending securities class action lawsuit that has been filed against the company and certain of its executives. The litigation, which seeks to represent investors who purchased or otherwise acquired Varonis common stock between February 4, 2025 and October 28, 2025, alleges that Varonis executives misled the market regarding the company's ability to convert its …

image for news VRNS Investor Alert: Hagens Berman Scrutinizing Varonis Systems (VRNS) Amid Claims of Alleged SaaS Transition Fraud in Securities Class Action

KLA Corporation Earnings Preview: What to Watch When KLAC Reports Today — Neutral

KLAC   24/7 Wall Street — January 29, 2026

Get earnings reminders, our top analysis on KLA, market updates, and brand-new stock recommendations delivered directly to your inbox.

image for news KLA Corporation Earnings Preview: What to Watch When KLAC Reports Today

Modine Manufacturing Company (MOD) Discusses Spin-Off and Combination of Performance Technologies Segment with Gentherm Transcript

image for news Modine Manufacturing Company (MOD) Discusses Spin-Off and Combination of Performance Technologies Segment with Gentherm Transcript

Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript — Neutral

SAN  SNY   Seeking Alpha — January 29, 2026

Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript

image for news Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript

Royal Caribbean Cruises Ltd. (RCL) Q4 2025 Earnings Call Transcript — Neutral

RCL   Seeking Alpha — January 29, 2026

Royal Caribbean Cruises Ltd. (RCL) Q4 2025 Earnings Call Transcript

image for news Royal Caribbean Cruises Ltd. (RCL) Q4 2025 Earnings Call Transcript

Visa Earnings Preview: What to Watch When V Reports Today — Neutral

V   24/7 Wall Street — January 29, 2026

Get earnings reminders, our top analysis on Visa, market updates, and brand-new stock recommendations delivered directly to your inbox.

image for news Visa Earnings Preview: What to Watch When V Reports Today

Partner Reed Kathrein Scrutinizing Claims of Detailed Hindsight Analysis Against Revealed Mechanical Write-Offs SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.

image for news ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments

Partner Reed Kathrein Scrutinizing Claims of High Conviction Against Revealed Construction Funding Collapse and 33% Stock Crash SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Fermi Inc. (NASDAQ: FRMI) regarding the March 6, 2026, lead plaintiff deadline in a pending securities class action against Fermi, certain of Fermi's top executives and directors, and underwriters of Fermi's Initial Public Offering (IPO). CLICK HERE TO SUBMIT YOUR FRMI LOSSES The litigation alleges that Fermi misrepresented the demand for its flagship "Project Matador"—a massive AI data center campus—and the …

image for news FRMI ALERT: Hagens Berman Scrutinizing Suit Against Fermi (FRMI) Over Alleged $150M Anchor Tenant Exit

After more than tripling revenue in 2025 and growing to 150+ employees, Omnea is stepping up investment in the US as enterprise adoption expands across customers including Spotify, MongoDB, McAfee, and Albertsons. After more than tripling revenue in 2025 and growing to 150+ employees, Omnea is stepping up investment in the US as enterprise adoption expands across customers including Spotify, MongoDB, McAfee, and Albertsons.

image for news Omnea doubles down on US growth with appointment of WiredScore founder Arie Barendrecht as US GM

Meta Platforms surges on earnings beat, upbeat outlook as AI boosts core business — Positive

META   Proactive Investors — January 29, 2026

Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) shares rose nearly 10% to about $735 following its latest earnings report, as Bank of America analysts highlighted accelerating advertising growth and early evidence that artificial intelligence investments are contributing to the company's core business. Meta reported fourth-quarter revenue of $59.9 billion and earnings of $8.88 per share, both above consensus estimates, and guided first-quarter revenue of $53.5 billion to $56.5 billion, exceeding Wall Street expectations.

image for news Meta Platforms surges on earnings beat, upbeat outlook as AI boosts core business

Oracle Stock Drops by More Than Half Amid AI Concerns — Negative

ORCL   PYMNTS — January 29, 2026

Shares in technology company Oracle have fallen by more than 50% from last year's record. As Bloomberg News reported Thursday (Jan. 29), the decline is happening as investors shed the stock over fears about the artificial intelligence (AI) market and the company's ties to OpenAI.

image for news Oracle Stock Drops by More Than Half Amid AI Concerns

Dover Corporation (DOV) Q4 2025 Earnings Call Transcript — Neutral

DOV   Seeking Alpha — January 29, 2026

Dover Corporation (DOV) Q4 2025 Earnings Call Transcript

image for news Dover Corporation (DOV) Q4 2025 Earnings Call Transcript

Trane Technologies plc (TT) Q4 2025 Earnings Call Transcript — Neutral

TT   Seeking Alpha — January 29, 2026

Trane Technologies plc (TT) Q4 2025 Earnings Call Transcript

image for news Trane Technologies plc (TT) Q4 2025 Earnings Call Transcript

Southwest Airlines Co. (LUV) Q4 2025 Earnings Call Transcript — Neutral

LUV   Seeking Alpha — January 29, 2026

Southwest Airlines Co. (LUV) Q4 2025 Earnings Call Transcript

image for news Southwest Airlines Co. (LUV) Q4 2025 Earnings Call Transcript

ASE Technology: AI Is Driving A Great LEAP Forward — Positive

ASX   Seeking Alpha — January 29, 2026

ASE Technology is well-positioned to capitalize on surging AI-driven demand for advanced semiconductor packaging, particularly from 2026 onward. ASX benefits from TSMC outsourcing high-end CoWoS packaging, supporting double-digit revenue growth and margin leverage as AI/HPC demand accelerates. Elevated capex—over 25% of revenue in 2025—is vital for expanding capacity for leading-edge packaging but should drive mid-teens revenue growth and mid-20% EBITDA margins.

image for news ASE Technology: AI Is Driving A Great LEAP Forward

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced topline results from its pivotal Phase 3 NEAT clinical trial evaluating its lead asset, dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP), in patients with Ataxia-Telangiectasia (A-T). In the NEAT study, the company's pivotal Phase 3 in.

image for news Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia